- Brief Report
- Open Access
Spontaneous splenic infarction associated with sumatriptan use
The Journal of Headache and Pain volume 7, pages214–216(2006)
Triptans are specific agonists of the serotonergic 5-HT1B/1D receptors that have increasingly been used in the treatment of migraine and cluster headaches. Though they are generally considered safe, there have been a few reports of myocardial infarction and stroke associated with triptan use. We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.
About this article
Cite this article
Arora, A., Arora, S. Spontaneous splenic infarction associated with sumatriptan use. J Headache Pain 7, 214–216 (2006). https://doi.org/10.1007/s10194-006-0291-5